Glenmark Pharmaceuticals has officially launched Tevimbra (tislelizumab), a novel lung cancer treatment, in India following approval from the Central Drugs Standard Control Organisation (CDSCO). This launch marks Glenmark’s first foray…
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry partners/sponsors sharing promotional product information via email and print communication from Asian Media Group USA Inc. and subsidiaries. You have the right to withdraw your consent at any time by clicking the unsubscribe link in our emails. We will use your email address to personalize our communications and send you relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at [email protected] to see how we manage and store your data.